Format

Send to

Choose Destination
J Biochem. 2015 Jan;157(1):1-12. doi: 10.1093/jb/mvu066. Epub 2014 Nov 7.

Glycobiology of α-dystroglycan and muscular dystrophy.

Author information

1
Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo 173-0015, Japan endo@tmig.or.jp.

Abstract

Most proteins are modified by glycans, which can modulate the biological properties and functions of glycoproteins. The major glycans can be classified into N-glycans and O-glycans according to their glycan-peptide linkage. This review will provide an overview of the O-mannosyl glycans, one subtype of O-glycans. Originally, O-mannosyl glycan was only known to be present on a limited number of glycoproteins, especially α-dystroglycan (α-DG). However, once a clear relationship was established between O-mannosyl glycan and the pathological mechanisms of some congenital muscular dystrophies in humans, research on the biochemistry and pathology of O-mannosyl glycans has been expanding. Because α-DG glycosylation is defective in congenital muscular dystrophies, which also feature abnormal neuronal migration, these disorders are collectively called α-dystroglycanopathies. In this article, I will describe the structure, biosynthesis and pathology of O-mannosyl glycans.

KEYWORDS:

O-mannosyl glycan; dystroglycan; glycan biosynthesis; glycosyltransferase; muscular dystrophy

PMID:
25381372
DOI:
10.1093/jb/mvu066
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center